Founded with a mission to revolutionize eye care through advanced technology, AEYE Health is an FDA-approved digital health startup specializing in AI-driven diagnostics. The company focuses on developing algorithms that provide immediate, autonomous interpretation of fundus images, targeting conditions such as diabetic retinopathy. Their innovative solutions are designed for use with both handheld and desktop retinal cameras, making high-quality eye care more accessible and efficient.
AEYE Health has garnered significant attention and investment from notable venture capital firms. The company's flagship product, AEYE-DS, is the first FDA-cleared AI technology capable of autonomously diagnosing diabetic retinopathy using portable retinal cameras. This groundbreaking achievement highlights their commitment to accuracy and accessibility, as evidenced by their clinical trial results showing 91% specificity and 93% sensitivity. AEYE Health's impact is profound, setting new standards in digital health and AI diagnostics.
